Acebron I, Chang M, Mobashery S, Hermoso J. (2015). The Allosteric Site for the Nascent Cell Wall in Penicillin- Binding Protein 2a: An Achilles’ Heel of Methicillin-Resistant Staphylococcus aureus, Current Medicinal Chemistry 22, 167886.
Alrabiah K, Alola SA, Banyan EA, Shaalan MA, Johani SA. (2016). Characteristics and risk factors of hospital acquired – Methicillin-resistant Staphylococcus aureus (HA- MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia, International Journal of Pediatrics and Adolescent Medicine 3, 71–7.
Balouiri M, Sadiki M, Ibnsouda SK. (2016). Methods for in vitro evaluating antimicrobial activity: A review, Journal of Pharmaceutical Analysis 6, 71–9
Fishovitz J, Rojas-Altuve A, Otero LH, Dawley M, Carrasco-López C, Chang M. (2014). Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics, Journal of the American Chemical Society 136, 9814–7.
Kelley WL, Jousselin A, Barras C, Lelong E, Renzoni A. (2015). Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998, Antimicrobial Agents and Chemotherapy 59, 1922–30.
Lahiri SD, Mclaughlin RE, Whiteaker JD, Ambler JE, Alm RA. (2015). Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline, Journal of Antimicrobial Chemotherapy 70, 2488–98.
Lim D and Strynadka NC. (2002). Structural Basis For The Βeta Lactam Resistance Of PBP2a From Methicillin Resistant Staphylococcus Aureus, Nature Structural Biology 9, 870-6.
Llarrull LI, Fisher JF, Mobashery S. (2009). Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New beta-Lactams That Meet the Challenge, Antimicrobial Agents and Chemotherapy 53, 4051–63.
Mahasenan KV, Molina R, Bouley R, Batuecas MT, Fisher JF, Hermoso JA, et al. (2017). Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis, Journal of the American Chemical Society 139, 2102–10.
Moellering, RC. (2011). MRSA: the first half century, Journal of Antimicrobial Chemotherapy 67, 4–11.
My NH, Hirao H, Van DU, Morokuma K. (2011). Computational Studies of Bacterial Resistance to β-Lactam Antibiotics: Mechanism of Covalent Inhibition of the Penicillin- Binding Protein 2a (PBP2a), Journal of Chemical Information and Modeling 51, 3226–34.
Otero LH, Rojas-Altuve A, Llarrull LI, Carrasco-Lopez C, Kumarasiri M, Lastochkin E. (2013). How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function, Proceedings of the National Academy of Sciences 110, 16808–13.
Roemer T, Schneider T, Pinho MG. (2013). Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics, Current Opinion in Microbiology 16, 538–48.
Schaumburg F, Peters G, Alabi A, Becker K, Idelevich EA. (2016). Missense mutations of PBP2a Are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA, Journal of Antimicrobial Chemotherapy 71, 41–4 .
Yang E, Tan J, Eells S, Rieg G, Tagudar G, Miller L. (2009). Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections, Clinical Microbiology and Infection 16, 425–31.